We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Blood Tests for Inflammation Can Be Discordant

By LabMedica International staff writers
Posted on 30 Oct 2012
Print article
The erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels are widely used tests of inflammation that sometimes show opposite results.

However, CRP and ESR may not correlate substantially in some conditions, and the extent to which CRP and ESR results agree with each other in an unselected patient population is not clear in clinical practice, as the results of the two tests are sometimes different.

Scientists at the Texas Health Presbyterian Hospital (Dallas, TX, USA) performed 2,150 paired CRP/ESR measurements in 1,753 patients, between January and December of 2011. There were 1,731 patients who were not pregnant and were all adults aged 18 years or more. Initial CRP and ESR results for each patient were divided into quartiles.

The CRP assay performed is based on a reaction between CRP in a serum or plasma sample and polyclonal anti-CRP antibodies that have been adsorbed to latex particles the Multigent CRP Vario Reagent, (Sentinel; Milan, Italy). Agglutination is detected as an absorbance change at 572 nm on the Architect c8000 (Abbott Laboratories; Abbott Park, IL, USA). The ESR assay samples are read with an ESR-Auto Plus instrument in QuickMode (Streck; Omaha, NE, USA) and converted to Westergren units. The results can range from zero to greater than 120 mm/hour.

The ages of the 105 patients in the high CRP/low ESR–discordant group and the 107 in the high ESR/low CRP–discordant group were similar. The high CRP/low ESR–discordant group had more patients with infections than the high ESR/low CRP–discordant group particularly infections in the urinary tract, gastrointestinal tract, lungs and bloodstream. However, they had fewer bone and joint infections than the high ESR/low CRP–discordant group.

Connective tissue diseases, such as systemic lupus erythematosus, were less common in the high CRP/low ESR–discordant group than in the high ESR/low CRP–discordant group. Ischemic strokes or transient ischemic attacks almost invariably occurred in the high ESR/low CRP–discordant group, whereas myocardial infarction or venous thromboembolism was limited to the high CRP/low ESR–discordant group. The authors concluded that their findings will provide information to physicians who order these two tests together and receive discordant results, which occurs in approximately one in eight patients. The study was published on August 23, 2012, in the journal Translational Research.

Related Links:

Texas Health Presbyterian Hospital
Sentinel
Abbott Laboratories


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Centromere B Assay
Centromere B Test
New
Dermatophytosis Rapid Diagnostic Kit
StrongStep Dermatophytosis Diagnostic Kit

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.